Sunshine Heart, Inc. (the Company or Sunshine Heart) is a Delaware incorporated company. On 28 September 2004, trading in CHESS depositary interests (CDIs) of Sunshine Heart commenced on the ASX under the stock ticker ‘SHC.’ Sunshine Heart had its Form 10 registration statement declared effective by the U.S. Securities and Exchange Commission (the SEC) on 14 February 2012. Trading on NASDAQ commenced on 16 February 2012 under the ticker ‘SSH.’
To assist all shareholders of Sunshine Heart, a list of Frequently Asked Questions in relation to these changes and the dual listing of Sunshine Heart on ASX and NASDAQ are set out below. To access the forms needed to convert CDIs to common stock and to convert common stock to CDIs, see Question 7.
Important Notice: The information in this document does not take into account your individual investment objectives, financial situation and needs. The information in this document is of a general nature and is not financial product advice and should not be relied upon as the sole basis for any investment decision. Shareholders should consult their financial, legal or tax adviser before deciding to buy or sell shares in Sunshine Heart. Your adviser may ask you for the Sunshine Heart CUSIP number. For your reference, Sunshine Heart’s CUSIP number is 86782U106.
Sunshine Heart was previously listed on the Australian Stock Exchange (ASX). On February 5, 2013, we received conditional approval from the ASX to delist from the official list of the ASX. The official delisting occurred at the close of trading on May 6, 2013.
Sunshine Heart’s latest Forms 10-K (annual) and 10-Q (Quarterly) can be found on Sunshine Heart’s investor relations web site as well as on the U.S. Securities and Exchange Commission web site. These filings include Sunshine Heart’s most recent annual and quarterly financial information that has been filed.
Please contact our transfer agent, American Stock Transfer & Trust Company (AST). Shareholders can call AST customer service at 1-800-937-5449 for transfers, address changes, or any other questions regarding their Sunshine Heart stock certificates.
Additionally, shareholders can mail correspondence to AST at the following address:
American Stock Transfer & Trust Company
59 Maiden Lane
New York, NY 10038
Sunshine Heart, Inc.
12988 Valley View Road
Eden Prairie, Minnesota USA
Blueprint Life Science Group
+1-415-375-3340, extension 103
You can also contact us through our online investor IR Contact Information form.
Please submit your question using the form below.